St.

Mary’s College
Bachelor of Science in Nursing
DRUG STUDY
Name of Patient: Attending Physician: Dr.
Chief Complaint: Submitted to:
Diagnosis:
Date Generic Brand Classification Indication Mechanism Dosage & Time Adverse Nursing Student’s CI’
Name Name of Action Frequenc Given Reaction Consideration Sign Sign
y
Fluvoxa Luvox Antidepressa Fluvoxamin Fluvoxami Adult: PO  Nausea Monitor for
mine nt e has been ne, Start with (40%) significant
shown to chemically 50 mg Headache nausea
significantly unrelated (22-35%) and
q.d., may
increase to other Somnolence vomiting,
plasma selective increase (22-27%)
slowly up especially
levels serotonin Weakness
to 300 during
of amitript reuptake (14-26%)
mg/d initial
yline, clomi inhibitors, Insomnia
pramine, a selectively given (20-35%) therapy.
nd blocks q.h.s. or Diarrhea (11-
other TRICY serotonin 18%) Monitor for
divided worsening
CLIC reuptake Dizziness
ANTIDEPRE b.i.d. of
by (11-15%)
SSANTS to inhibiting Child: PO  Xerostomia depressio
mildly the 8–11 (10-14%) n or
increase serotonin y, Start Anorexia (6- emergenc
levels of reuptake with 25 14%) e of
their pump at Abnormal
mg q.h.s., suicidal
metabolites. the ejaculation
May may
antagonize presynaptic increase (8-11%)
the blood neuronal by 25 mg ideations.
1-10%
pressure- membrane. q4–7d
lowering Pain (10%) Assess
(max: 200
effects Dyspepsia safety;
of atenolol  mg/d in (8-10%) drowsines
and divided Constipation s and
other BETA doses) (4-10%) dizziness
BLOCKERS. Decreased are
May libido (2-
increase common
10%)
levels and Upper adverse
toxicity respiratory effects.
of carbama infections
zepine, mex (9%) Monitor
iletine. May Anxiety (5- PT and
increase lith 8%) INR
ium levels Tremor (5- carefully
causing 8%) with
neurotoxicit Sweating (6- concurrent
y, serotonin  7%) warfarin
syndrome, Vomiting (4- therapy;
somnolence 6%) adjust
, and Abdominal
warfarin
mania.  pain (5%)
as
Myalgia (5%)
Abnormal needed.
taste (2-5%)
Bruising (4%) Patient &
Abnormal Family
dreams (3%) Education
Abnormal
thinking (3%) Note:
Chest pain
(3%) Nausea
Palpitation and
(3%) vomiting
are
common
in early
therapy.
Notify
physician
if these
adverse
effects last
more than
a few
days.

Exercise
caution
with
hazardous
activity
until
response
to the drug
is known.

Do not
breast
feed while
taking this
drug
without
consulting
physician.